GT Biopharma, Inc.

GTBP · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 1 employees
406
SEC Filings
$7.1
Close 2026-09-23
1
Employees

Business Summary

GT Biopharma, Inc. is a clinical stage biopharmaceutical company developing novel immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) and Tetra-specific Killer Engager (Dual Targeting TriKE) fusion protein platforms. These platforms harness patients' natural killer (NK) cells to target cancer cells. Key pipeline candidates include GTB-3650 (AML/MDS), GTB-5550 (B7-H3+ solid tumors), and GTB-7550 (autoimmune disorders). The company conducts no manufacturing, relying on third-party CMOs.

Latest Stock Quote

GTBP 2026-09-23 $7.1 O:$7.08 H:$7.2751 L:$6.825 Vol:0.1M VWAP:$7.0325
origin leaf: null

Next Earnings

expected 2026-12-25

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001493152-26-008443EDGAR63K words
2025-02-212024-12-310001493152-25-007908EDGAR56K words
2024-03-262023-12-310001493152-24-011332EDGAR48K words
2023-03-302022-12-310001493152-23-009812EDGAR—
2022-03-282021-12-310001493152-22-007883EDGAR—
2021-04-162020-12-310001654954-21-004295EDGAR—
2020-03-272019-12-310001654954-20-003380EDGAR—
2019-03-292018-12-310001654954-19-003697EDGAR—
2018-03-012017-12-310001654954-18-002054EDGAR—
2017-03-312016-12-310001654954-17-002919EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001493152-26-037988EDGAR22K words
2025-11-142025-09-300001493152-25-023400EDGAR26K words
2025-08-142025-06-300001493152-25-011971EDGAR25K words
2025-05-152025-03-310001641172-25-010790EDGAR19K words
2024-11-142024-09-300001493152-24-045892EDGAR21K words
2024-08-142024-06-300001493152-24-032143EDGAR21K words
2024-05-152024-03-310001493152-24-019970EDGAR18K words
2023-11-012023-09-300001493152-23-038957EDGAR20K words
2023-08-072023-06-300001493152-23-026973EDGAR20K words
2023-05-152023-03-310001493152-23-017492EDGAR17K words
2022-10-312022-09-300001493152-22-030019EDGAR—
2022-08-152022-06-300001493152-22-022629EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-250001493152-26-044309EDGAR1K words
2026-09-210001493152-26-043562EDGAR1K words
2026-09-150001493152-26-042672EDGAR25K words
2026-09-030001493152-26-041333EDGAR2K words
2026-08-140001493152-26-038446EDGAR1K words
2026-03-020001493152-26-008442EDGAR3K words
2025-11-260001493152-25-025162EDGAR1K words
2025-11-140001493152-25-022631EDGAR1K words
2025-09-260001493152-25-015725EDGAR1K words
2025-09-230001493152-25-014684EDGAR1K words

406 total filings indexed. 374 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

acute-myeloid-leukemia-(aml) myelodysplastic-syndromes-(mds) b7-h3-positive-solid-tumors autoimmune-disorders hematologic-malignancies immuno-oncology fda-current-good-manufacturing-practices-(cgmp) ind-(investigational-new-drug)-application-process

Company Identity

CIK0000109657
TickerGTBP
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.gtbiopharma.com
Listed2021-02-11

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 1e168ef28a410a822ee32fa19ef1ca662c13312bb31deeb947d34235f2a97897
parent: 474c2a083335b88a01b16a41d2d16cad411b4f27278ab878494ab0fe60eaf2d7
content hash: 14f75069c2f6534f95602a89755c0d2eb2a1b4222670467a85c9b364b9443236
signed: 2026-09-28T19:01:32.047Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up GTBP using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on GTBP, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/GTBP (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.